Avita Medical
AVITA Medical is a leading therapeutic acute wound care company dedicated to transforming lives through innovative skin healing technologies. Their platform includes the FDA-approved RECELL System, which harnesses the healing properties of a patient’s own skin to create Spray-On Skin cells, providing an innovative solution for burn, trauma, or surgical wounds. The company also holds exclusive rights to market, sell, and distribute biosynthetic wound matrices like PermeaDerm and Cohealyx, and is exploring the potential of their technology platform across various skin-related indications. AVITA Medical emphasizes patient-centered care, innovation, quality, and integrity in their mission to improve clinical outcomes and accelerate patient recovery.
Industries
Nr. of Employees
medium (51-250)
Avita Medical
Valencia, California, United States, North America
Products
Autologous spray-on skin cell system (point-of-care)
A clinical system that prepares an autologous cell suspension from a small skin sample for immediate application to wounds at the point-of-care to promote skin healing.
Biosynthetic primary wound dressing
A biosynthetic wound matrix designed to function as a primary dressing that adheres in a single application for wound management.
Collagen-based dermal matrix for full-thickness wounds
A collagen dermal matrix intended for management of full-thickness wounds.
Autologous spray-on skin cell system (point-of-care)
A clinical system that prepares an autologous cell suspension from a small skin sample for immediate application to wounds at the point-of-care to promote skin healing.
Biosynthetic primary wound dressing
A biosynthetic wound matrix designed to function as a primary dressing that adheres in a single application for wound management.
Collagen-based dermal matrix for full-thickness wounds
A collagen dermal matrix intended for management of full-thickness wounds.
Services
Clinical training and point-of-care implementation support
Education and training for healthcare professionals on the preparation and application of autologous cell suspensions and use of wound matrices.
Clinical evidence generation and trial execution
Design and conduct of clinical studies and collection of patient outcomes and real-world evidence to support regulatory submissions and publications.
Clinical training and point-of-care implementation support
Education and training for healthcare professionals on the preparation and application of autologous cell suspensions and use of wound matrices.
Clinical evidence generation and trial execution
Design and conduct of clinical studies and collection of patient outcomes and real-world evidence to support regulatory submissions and publications.
Expertise Areas
- Autologous cellular therapy development
- Acute wound care and burn treatment
- Clinical trial management and real-world evidence generation
- Regulatory compliance and market authorization
Key Technologies
- Autologous cell suspension (spray-on) therapy
- Point-of-care cell processing
- Biosynthetic wound matrix materials
- Collagen-based dermal matrices